Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
INVA Innoviva Inc
APT Alpha Pro Tech Ltd
PTC PTC Inc
AIC Arlington Asset Investment Corp
PSAGW Property Solutions Acquisition Corp II *W EXP 03/01/2026
AMZN Amazon.com Inc
GSK GlaxoSmithKline PLC
TSLA Tesla Inc
MMD MainStay MacKay DefinedTerm Municipal Opportunities Fund
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine is developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a novel biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Postmarket

Last Trade
Delayed
$9.26
0.60 (6.93%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$8.66
Day's Change
-1.39 (-13.83%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
10.07
Day's Low
8.56
Volume
(Heavy Day)
Volume:
41,097,001

10-day average volume:
31,046,379
41,097,001
  • Prev Close
    10.05
  • Today's Open
    10.06
  • Day's Range
    8.56-10.07
  • Avg Vol (10-day)
    31.0M
  • Last (time)
    4:00p ET 10/15/21
  • Last (size)
    70
  • 52-Wk Range
    0.2501 - 18.77
    LowHigh
  • (11/02/20 - 02/08/21)
    3,362.61%
  • 245.8%
  • Market Cap
    1.7B
  • Shares Outstanding
    198.8M
  • -0.27
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.4
  • 27.14
  • (% of float 09/30/21)
    27.37

Latest News

October 15, 2021
10:45 am ET
PR Newswire
October 14, 2021
5:13 pm ET
MarketWatch
11:00 am ET
PR Newswire
October 13, 2021
5:13 pm ET
MarketWatch
10:46 am ET
PR Newswire
October 12, 2021
5:13 pm ET
MarketWatch
8:32 am ET
PR Newswire
October 11, 2021
5:13 pm ET
MarketWatch
October 08, 2021
10:50 pm ET
BusinessWire
5:13 pm ET
MarketWatch
October 07, 2021
5:13 pm ET
MarketWatch
October 06, 2021
5:13 pm ET
MarketWatch
9:31 am ET
PR Newswire
October 05, 2021
5:13 pm ET
MarketWatch
8:30 am ET
PR Newswire
October 04, 2021
5:13 pm ET
MarketWatch
October 01, 2021
5:13 pm ET
MarketWatch
September 30, 2021
5:13 pm ET
MarketWatch
September 29, 2021
5:13 pm ET
MarketWatch
September 28, 2021
5:13 pm ET
MarketWatch
September 27, 2021
5:13 pm ET
MarketWatch
September 24, 2021
10:50 pm ET
PR Newswire
5:13 pm ET
MarketWatch
September 23, 2021
5:13 pm ET
MarketWatch
4:08 pm ET
Globe Newswire
September 22, 2021
5:13 pm ET
MarketWatch
September 21, 2021
5:14 pm ET
MarketWatch
September 20, 2021
5:13 pm ET
MarketWatch
September 17, 2021
5:13 pm ET
MarketWatch
4:52 pm ET
Globe Newswire
September 16, 2021
5:14 pm ET
MarketWatch
September 15, 2021
5:13 pm ET
MarketWatch
September 14, 2021
5:13 pm ET
MarketWatch
1:23 pm ET
PR Newswire
September 13, 2021
5:13 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.